Viewing Study NCT03258567


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-03-11 @ 11:39 AM
Study NCT ID: NCT03258567
Status: RECRUITING
Last Update Posted: 2025-12-08
First Post: 2017-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module